nexgel inc - NXGL

NXGL

Close Chg Chg %
0.32 -0.02 -6.07%

Pre-Market

0.30

-0.02 (6.07%)

Volume: 160.63K

Last Updated:

Sep 8, 2026, 4:00 PM EDT

Company Overview: nexgel inc - NXGL

NXGL Key Data

Open

$0.33

Day Range

0.29 - 0.33

52 Week Range

0.29 - 2.89

Market Cap

$3.12M

Shares Outstanding

9.75M

Public Float

8.30M

Beta

0.75

Rev. Per Employee

N/A

P/E Ratio

N/A

EPS

-$0.72

Yield

0.00%

Dividend

N/A

EX-DIVIDEND DATE

SHORT INTEREST

N/A

AVERAGE VOLUME

1.68M

 

NXGL Performance

1 Week
 
-6.07%
 
1 Month
 
-21.76%
 
3 Months
 
-46.04%
 
1 Year
 
-87.66%
 
5 Years
 
N/A
 

NXGL Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 1
Full Ratings ➔

About nexgel inc - NXGL

NexGel, Inc. engages in the manufacture of aqueous polymer hydrogels used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. It operates through the NexGel and CGN segments. The NexGel segment consists of the manufacturing of ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications, which is based in Langhorne, Pennsylvania. The CGN segment consists of the CGN JV used for the company’s converting and packaging business, which is based in Granbury, Texas. The company was founded on January 13, 2009, and is headquartered in Langhorne, PA.

NXGL At a Glance

NexGel, Inc.
2150 Cabot Boulevard West
Langhorne, Pennsylvania 19047
Phone 1-215-702-8550 Revenue 11.42M
Industry Chemicals: Specialty Net Income -3,000,000.00
Sector Process Industries 2025 Sales Growth 31.457%
Fiscal Year-end 12 / 2026 Employees 19
View SEC Filings

NXGL Valuation

P/E Current N/A
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) N/A
Price to Sales Ratio 1.107
Price to Book Ratio 2.94
Price to Cash Flow Ratio N/A
Enterprise Value to EBITDA -5.784
Enterprise Value to Sales 1.323
Total Debt to Enterprise Value 0.204

NXGL Efficiency

Revenue/Employee 601,105.263
Income Per Employee -157,894.737
Receivables Turnover 16.97
Total Asset Turnover 1.065

NXGL Liquidity

Current Ratio 1.468
Quick Ratio 0.753
Cash Ratio 0.358

NXGL Profitability

Gross Margin 39.48
Operating Margin -29.349
Pretax Margin -25.331
Net Margin -26.267
Return on Assets -27.98
Return on Equity -58.743
Return on Total Capital -39.751
Return on Invested Capital -39.316

NXGL Capital Structure

Total Debt to Total Equity 69.253
Total Debt to Total Capital 40.917
Total Debt to Total Assets 29.519
Long-Term Debt to Equity 58.623
Long-Term Debt to Total Capital 34.636
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Nexgel Inc - NXGL

Collapse All in section
All values USD millions. 2022 2023 2024 2025 5-year trend
Sales/Revenue
2.05M 4.09M 8.69M 11.42M
Sales Growth
+32.04% +99.66% +112.47% +31.46%
Cost of Goods Sold (COGS) incl D&A
1.81M 3.60M 6.10M 6.91M
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
301.00K 443.00K 480.00K 740.00K
Depreciation
288.00K 349.00K 361.00K 614.00K
Amortization of Intangibles
13.00K 94.00K 119.00K 126.00K
COGS Growth
+16.27% +98.89% +69.52% +13.39%
Gross Income
240.00K 493.00K 2.59M 4.51M
Gross Income Growth
+6,100.00% +105.42% +425.76% +73.96%
Gross Profit Margin
+11.72% +12.06% +29.83% +39.48%
2022 2023 2024 2025 5-year trend
SG&A Expense
3.59M 3.97M 6.15M 7.86M
Research & Development
367.00K 103.00K 78.00K 2.00K
Other SG&A
3.22M 3.87M 6.07M 7.86M
SGA Growth
+39.83% +10.65% +54.81% +27.90%
Other Operating Expense
- - - -
-
Unusual Expense
65.00K (96.00K) (10.00K) (118.00K)
EBIT after Unusual Expense
(3.41M) (3.38M) (3.54M) (3.23M)
Non Operating Income/Expense
3.00K 208.00K 162.00K 375.00K
Non-Operating Interest Income
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
1.34M 15.00K 81.00K 34.00K
Interest Expense Growth
-33.13% -98.88% +440.00% -58.02%
Gross Interest Expense
1.34M 15.00K 81.00K 34.00K
Interest Capitalized
- - - -
-
Pretax Income
(4.75M) (3.19M) (3.46M) (2.89M)
Pretax Income Growth
-10.12% +32.83% -8.63% +16.46%
Pretax Margin
-231.74% -77.97% -39.86% -25.33%
Income Tax
- - - -
-
Income Tax - Current - Domestic
- - (801.00K) (529.00K)
-
Income Tax - Current - Foreign
- - - -
-
Income Tax - Deferred - Domestic
- - 801.00K 529.00K
-
Income Tax - Deferred - Foreign
- - - -
-
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
(4.75M) (3.19M) (3.46M) (2.89M)
Minority Interest Expense
- (31.00K) (182.00K) 107.00K
Net Income
(4.75M) (3.16M) (3.28M) (3.00M)
Net Income Growth
-10.12% +33.48% -3.93% +8.56%
Net Margin Growth
-231.74% -77.21% -37.76% -26.27%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
(4.75M) (3.16M) (3.28M) (3.00M)
Preferred Dividends
- - - -
-
Net Income Available to Common
(4.75M) (3.16M) (3.28M) (3.00M)
EPS (Basic)
-0.8513 -0.5566 -0.5039 -0.382
EPS (Basic) Growth
-10.06% +34.62% +9.47% +24.19%
Basic Shares Outstanding
5.57M 5.67M 6.51M 7.85M
EPS (Diluted)
-0.8513 -0.5566 -0.5039 -0.382
EPS (Diluted) Growth
-10.06% +34.62% +9.47% +24.19%
Diluted Shares Outstanding
5.57M 5.67M 6.51M 7.85M
EBITDA
(3.05M) (3.03M) (3.07M) (2.61M)
EBITDA Growth
-24.01% +0.43% -1.32% +15.03%
EBITDA Margin
-148.78% -74.20% -35.38% -22.87%

Snapshot

Average Recommendation HOLD Average Target Price 2.00
Number of Ratings 1 Current Quarters Estimate -0.24
FY Report Date 09 / 2026 Current Year's Estimate -0.94
Last Quarter’s Earnings -0.40 Median PE on CY Estimate N/A
Year Ago Earnings -0.38 Next Fiscal Year Estimate -0.22
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 1 1 1 1
Mean Estimate -0.24 -0.20 -0.94 -0.22
High Estimates -0.24 -0.20 -0.94 -0.22
Low Estimate -0.24 -0.20 -0.94 -0.22
Coefficient of Variance N/A N/A N/A N/A

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 0 0 1
OVERWEIGHT 0 0 0
HOLD 1 1 0
UNDERWEIGHT 0 0 0
SELL 0 0 0
MEAN Hold Hold Buy

Nexgel Inc in the News